Financials in USD. Standardized financial statements.
A compact view of how ImpediMed Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $12.72M | $10.05M | $11.34M | $10.49M | $8.35M | $5.69M | $4.10M | $4.80M | $5.77M | $5.79M |
| Revenue Growth? | +26.6% | -11.4% | +8.1% | +25.6% | +46.7% | +38.9% | -14.6% | -16.8% | -0.4% | 0.0% |
| Cost of Revenue? | $1.75M | $1.31M | $25.00M | $1.71M | $1.60M | $1.68M | $1.25M | $1.60M | $1.49M | $1.58M |
| Gross Profit? | $10.97M | $8.74M | -$13.65M | $8.79M | $6.75M | $4.02M | $2.85M | $3.20M | $4.28M | $4.21M |
| Gross Margin? | +86.3% | +86.9% | -120.4% | +83.7% | +80.8% | +70.5% | +69.4% | +66.7% | +74.2% | +72.7% |
| Operating Expenses? | $35.21M | $33.04M | $9.19M | $30.32M | $29.82M | $29.57M | $29.86M | $33.84M | $35.05M | $30.39M |
| Operating Income? | -$24.23M | -$24.30M | -$22.85M | -$21.54M | -$23.07M | -$25.56M | -$27.01M | -$30.64M | -$30.77M | -$26.18M |
| EBITDA? | -$17.55M | -$22.05M | -$20.49M | -$18.77M | -$21.37M | -$24.12M | -$26.33M | -$30.18M | -$30.50M | -$26.00M |
| Income Before Tax | -$23.21M | -$19.76M | -$22.08M | -$19.83M | -$20.67M | -$21.33M | -$23.95M | -$27.13M | -$27.53M | -$25.98M |
| Income Tax Expense | $26,000 | $33,000 | -$1.55M | $46,000 | $39,000 | $48,000 | $51,000 | $42,000 | $40,000 | -$156,000 |
| Net Income? | -$23.24M | -$19.79M | -$20.52M | -$19.87M | -$20.71M | -$21.38M | -$24.12M | -$27.17M | -$27.57M | -$25.98M |
| EPS? | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.04 | $-0.06 | $-0.07 | $-0.07 | $-0.08 |
| Diluted EPS? | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.04 | $-0.06 | $-0.07 | $-0.07 | $-0.08 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality